Biopharmaceutical firm UCB to invest £1bn in UK for research and development

This article was originally published here

UCB will build a new £150mto £200m research and development facility as part of the total investment over the next five years. The transition to the facility will

The post Biopharmaceutical firm UCB to invest £1bn in UK for research and development appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply